Publikationen von A. Erhardt

Erhardt, A.; Welt, T.; Rödel, A.; Habersetzer, U.; Stecker, G.; Ohl, F.; Keck, M. E.: Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice - influence of CRH1-receptor antagonism. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Erhardt, A.; Welt, T.; Schmidt, W.; Sillaber, I.; Keck, M. E.: Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal. Pharmacopsychiatry 36 (5), S. 223 - 224 (2003)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), S. 239 - 239 (2003)

Keck, M. E.; Welt, T.; Erhardt, A.; Müller, M. B.; Sillaber, I.: Neuroendokrine Effekte der repetitiven transkraniellen Magnetstimulation. Fokus auf Dopamin und Vasopressin. Nervenheilkunde 22 (7), S. 346 - 349 (2003)

Czéh, B.; Welt, T.; Fischer, A. K.; Erhardt, A.; Schmitt, W.; Müller, M. B.; Toschi, N.; Fuchs, E.; Keck, M. E.: Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: Effects on stress hormone levels and adult hippocampal neurogenesis. Biological Psychiatry 52 (11), S. 1057 - 1065 (2002)

Erhardt, A.: Candidate genes involved in the aetiology and therapy response in panic disorder. 30th Congress of the European College of Neuropsychopharmacology (ECNP), Paris, FRANCE, 02. September 2017 - 05. September 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 4), S.08.02, S. S534 - S534 (2017)

Forstner, A. J.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Hovatta, L.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D.; Mors, O. et al.; Müller-Myhsok, B.; Binder, E. B.; Rueck, C.; Deckert, J.; Schumacher, J.: GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl.2), Su19, S. S217 - S218 (2017)

Gregersen, N.; Buttenschon, H. N.; Hedemand, A.; Nielsen, M. N.; Dahl, H. A.; Kristensen, A. S.; Johansen, O.; Woldbye, D. P. D.; Erhardt, A.; Kruse, T. A. et al.; Wang, A. G.; Borglum, A. D.; Mors, O.: ASSOCIATION BETWEEN GENES ON CHROMOSOME 19P32.2 AND PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 2), Sa22, S. S160 - S160 (2017)

Iurato, S.; Carrillo-Roa, T.; Arloth, J.; Czamara, D.; Ising, M.; Lucae, S.; Müller-Myhsok, B.; Binder, E.; Erhardt, A.: SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 3), T24, S. S446 - S447 (2017)

Iurato, S.; Carrillo-Roa, T.; Ising, M.; Lucae, S.; Binder, E.; Erhardt, A.: EPIGENOME-WIDE ASSOCIATION STUDY (EWAS) IN A PANIC DISORDER COHORT. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 2), Su48, S. S231 - S231 (2017)

Peterse, Y.; Spoormaker, V.; Erhardt, A.; Binder, E.; Saemann, P.; Czisch, M.: The neural correlates of fear generalization and its moderation by genetically determined risk for panic disorder. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, GERMANY, 14. September 2017 - 16. September 2017. JOURNAL OF NEURAL TRANSMISSION 124 (10), 150, S. 1295 - 1295 (2017)

Schumacher, J.; Forstner, A. J.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Hovatta, I.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D. et al.; Mors, O.; Ripke, S.; Binder, E.; Ruck, C.; Deckert, J.: GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 3), S. S502 - S502 (2017)

Naamanka, J.; Tasanko, E.; Trontti, K.; Novak, B.; Suvisaari, J.; Paunio, T.; Vaht, M.; Mattheisen, M.; Meier, S.; Metspalu, A. et al.; Daly, M.; Erhardt-Lehmann, A.; Turck, C. W.; Hartiala, J. A.; Hovatta, I.: GENOME-WIDE ANALYSIS IDENTIFIES SORCS3 AS A NOVEL SUSCEPTIBILITY LOCUS FOR PANIC DISORDER IN THE FINNGEN STUDY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 63, S. E101 - E101. (2022)

Erhardt-Lehmann, A.: Stress-induced changes in DNA-methylation: focus on anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 128 (11), S. 1798 - 1798. (2021)

Erhardt, A.: Genetics and epigenetics of panic disorder. In Journal of Neural Transmission, 126 (11), S. 1564 - 1565. International Congress of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Wurzburg, GERMANY, 03. Oktober 2019 - 05. Oktober 2019. Springer-Verlag., Wien (2019)

Forstner, A. J.; Awasthi, S.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D.; Mors, O. et al.; Binder, E. B.; Ruck, C.; Ripke, S.; Deckert, J.; Schumacher, J.: Genome-wide association study of panic disorder. In European Neuropsychopharmacology, 29, S. S776 - S776. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, 13. Oktober 2017 - 17. Oktober 2017. Elsevier, Amsterdam (2019)

Forstner, A. J.; Awasthi, S.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D.; Mors, O. et al.; Binder, E. B.; Ruck, C.; Ripke, S.; Deckert, J.; Schumacher, J.: GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S. S776 - S776. 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, 13. Oktober 2017 - 17. Oktober 2017. (2019)

Nakano, W.; Mehta, D.; Ising, M.; Pfister, H.; Czamara, D.; Carrillo Roa, T.; Holsboer, F.; Lucae, S.; Erhardt, A.; Binder, E.: Genetic predictor of antidepressant response for major depressive disorder accounting for clinical subgroups: A genome-wide association study. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17, RA-01-003, S. 42 - 42. 29th CINP World Congress of Neuropsychopharmacology , Vancouver, Canada, 22. Juni 2014 - 26. Juni 2014. Oxford University Press, Oxford, UK (2014)

Erhardt, A.: Einfluß der repetitiven transkraniellen Magnetstimulation (rTMS) auf das mesolimbische dopaminerge System bei drogennaiven und morphinvorbehandelten Ratten. Dissertation, Ludwig-Maximillians-Universität, München (2003)

Scherf-Clavel, M.; Weber, H.; Deckert, J.; Erhardt-Lehmann, A.: The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)